Open Access
,
volume 11
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
Olayinka O Ogunleye
1, 2
,
Debashis Basu
3, 4
,
Debjani Mueller
5
,
Jacqueline Sneddon
6
,
R. Andrew Seaton
6, 7, 8
,
Adesola F Yinka Ogunleye
9
,
Joshua Wamboga
10
,
Nenad Miljković
11
,
Julius C Mwita
12
,
Godfrey Mutashambara Rwegerera
13
,
Amos Massele
14
,
Patrick Okwen
15, 16
,
Loveline Lum Niba
15, 17
,
Melaine Nsaikila
15
,
Wafaa M Rashed
18
,
Mohamed Ali Hussein
18
,
Rehab Hegazy
19
,
Adefolarin A Amu
20
,
Baffour Boaten Boahen-Boaten
21
,
Zinhle Matsebula
22
,
Prudence Gwebu
22
,
Bongani Chirigo
22
,
Nongabisa Mkhabela
22
,
Tenelisiwe Dlamini
22
,
Siphiwe Sithole
22
,
Sandile Malaza
22
,
Sikhumbuzo Dlamini
22
,
Daniel Afriyie
23
,
George Awuku Asare
24
,
Seth Kwabena Amponsah
25
,
Israel Sefah
26, 27
,
Margaret Oluka
28
,
Anastasia N Guantai
28
,
Sylvia A Opanga
29
,
Tebello Violet Sarele
30
,
Refeletse Keabetsoe Mafisa
31
,
Ibrahim Chikowe
32
,
Felix Khuluza
32
,
Dan Kibuule
33
,
Francis Kalemeera
33
,
Mwangana Mubita
33
,
Joseph Fadare
34, 35
,
Laurien Sibomana
36
,
Gwendoline Malegwale Ramokgopa
3, 4
,
Carmen Whyte
3, 4
,
Tshegofatso Maimela
3, 4
,
Johannes Hugo
4, 37
,
Johanna C. Meyer
38
,
Natalie Schellack
38
,
Enos M Rampamba
38, 39
,
Adel Visser
40
,
Abubakr Alfadl
41, 42
,
Elfatih M Malik
43, 44
,
Oliver Ombeva Malande
45, 46
,
Aubrey C Kalungia
47
,
Chiluba Mwila
47
,
Trust Zaranyika
48
,
Blessmore Vimbai Chaibva
49
,
Ioana D. Olaru
50, 51
,
Nyasha Masuka
52
,
Janney Wale
53
,
Lenias Hwenda
54
,
Regina Kamoga
10, 55
,
Ruaraidh Hill
56
,
Corrado Barbui
57
,
Tomasz Bochenek
58
,
Amanj Kurdi
59, 60
,
Stephen Campbell
61, 62
,
Antony P Martin
63, 64
,
Thuy Nguyen Thi Phuong
65
,
Nguyen Thanh Binh
65
,
Brian Godman
38, 59, 66, 67
4
WHO Collaborating Centre for Social Determinants of Health and Health in all Policies, South Africa
|
5
Charlotte Maxeke Medical Research Cluster, South Africa
|
6
Healthcare Improvement Scotland, United Kingdom
|
7
Queen Elizabeth University Hospital, United Kingdom
|
9
Department of Surveillance and Epidemiology, Nigerian Centre for Disease Control, Nigeria
|
10
Uganda Alliance of Patients’ Organizations (UAPO), Uganda
|
15
Effective Basic Services (eBASE) Africa, Cameroon
|
18
Children's Cancer Hospital, Egypt
|
19
Pharmacology Department, Medical Division, National Research Centre, Egypt
|
22
Raleigh Fitkin Memorial Hospital, Eswatini
|
23
Pharmacy Department, Ghana Police Hospital, Ghana
|
26
Ghana Health Service, Pharmacy Department, Keta Municipal Hospital, Ghana
|
27
29
31
Independent Researcher, Lesotho
|
37
39
Department of Pharmacy, Tshilidzini Hospital, South Africa
|
40
Eugene Marais Hospital, South Africa
|
41
National Medicines Board, Federal Ministry of Health, Sudan
|
44
Community Medicine Council, SMSB, Sudan
|
46
East Africa Centre for Vaccines and Immunization (ECAVI), Uganda
|
49
Ministry of Health and Child Care, Zimbabwe
|
51
Biomedical Research and Training Institute, Zimbabwe
|
52
Zimbabwe College of Public Health Physicians, Zimbabwe
|
53
Independent Consumer Advocate, Australia
|
54
Medicines for Africa, South Africa
|
55
Community Health and Information Network (CHAIN), Uganda
|
59
62
64
HCD Economics, The Innovation Centre, United Kingdom
|
66
Publication type: Journal Article
Publication date: 2020-09-11
scimago Q1
wos Q1
SJR: 1.220
CiteScore: 8.9
Impact factor: 4.8
ISSN: 16639812
PubMed ID:
33071775
Pharmacology
Pharmacology (medical)
Abstract
Background: The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. Objective: Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. Our Approach: Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. Ongoing activities: Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma. Strategies include extending prescription lengths, use of drones, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality Conclusion: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can be catastrophic, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
|
|
|
Antibiotics
10 publications, 6.58%
|
|
|
Frontiers in Public Health
9 publications, 5.92%
|
|
|
Vaccines
7 publications, 4.61%
|
|
|
International Journal of Environmental Research and Public Health
6 publications, 3.95%
|
|
|
Frontiers in Pharmacology
5 publications, 3.29%
|
|
|
Advances in Human Biology
5 publications, 3.29%
|
|
|
Health Promotion Practice
4 publications, 2.63%
|
|
|
PLoS ONE
3 publications, 1.97%
|
|
|
Expert Review of Anti-Infective Therapy
3 publications, 1.97%
|
|
|
BMJ Global Health
3 publications, 1.97%
|
|
|
Pharmacy Education
3 publications, 1.97%
|
|
|
PLOS Global Public Health
3 publications, 1.97%
|
|
|
Open Research Europe
3 publications, 1.97%
|
|
|
Cureus
2 publications, 1.32%
|
|
|
Healthcare
2 publications, 1.32%
|
|
|
Malaria Journal
2 publications, 1.32%
|
|
|
Infection and Drug Resistance
2 publications, 1.32%
|
|
|
Journal of Multidisciplinary Healthcare
2 publications, 1.32%
|
|
|
British Journal of Clinical Pharmacology
2 publications, 1.32%
|
|
|
Diseases
1 publication, 0.66%
|
|
|
Development Southern Africa
1 publication, 0.66%
|
|
|
Open Research Africa
1 publication, 0.66%
|
|
|
Health security
1 publication, 0.66%
|
|
|
Breast Cancer: Targets and Therapy
1 publication, 0.66%
|
|
|
Journal of Developing Societies
1 publication, 0.66%
|
|
|
Nursing Ethics
1 publication, 0.66%
|
|
|
Life
1 publication, 0.66%
|
|
|
Applied Sciences (Switzerland)
1 publication, 0.66%
|
|
|
Water (Switzerland)
1 publication, 0.66%
|
|
|
2
4
6
8
10
|
Publishers
|
5
10
15
20
25
30
35
|
|
|
MDPI
31 publications, 20.39%
|
|
|
Taylor & Francis
26 publications, 17.11%
|
|
|
Springer Nature
15 publications, 9.87%
|
|
|
Frontiers Media S.A.
15 publications, 9.87%
|
|
|
Elsevier
13 publications, 8.55%
|
|
|
Wiley
8 publications, 5.26%
|
|
|
SAGE
7 publications, 4.61%
|
|
|
Public Library of Science (PLoS)
6 publications, 3.95%
|
|
|
Medknow
5 publications, 3.29%
|
|
|
F1000 Research
4 publications, 2.63%
|
|
|
BMJ
4 publications, 2.63%
|
|
|
Oxford University Press
3 publications, 1.97%
|
|
|
Cold Spring Harbor Laboratory
3 publications, 1.97%
|
|
|
JMIR Publications
2 publications, 1.32%
|
|
|
Mary Ann Liebert
1 publication, 0.66%
|
|
|
Tech Science Press
1 publication, 0.66%
|
|
|
Hindawi Limited
1 publication, 0.66%
|
|
|
AIP Publishing
1 publication, 0.66%
|
|
|
Emerald
1 publication, 0.66%
|
|
|
Korean Society of Global Health
1 publication, 0.66%
|
|
|
AOSIS
1 publication, 0.66%
|
|
|
5
10
15
20
25
30
35
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
152
Total citations:
152
Citations from 2024:
30
(19.74%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Ogunleye O. O. et al. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future // Frontiers in Pharmacology. 2020. Vol. 11.
GOST all authors (up to 50)
Copy
Ogunleye O. O. et al. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future // Frontiers in Pharmacology. 2020. Vol. 11.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3389/fphar.2020.01205
UR - https://doi.org/10.3389/fphar.2020.01205
TI - Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
T2 - Frontiers in Pharmacology
AU - Ogunleye, Olayinka O
AU - Basu, Debashis
AU - Mueller, Debjani
AU - Sneddon, Jacqueline
AU - Seaton, R. Andrew
AU - Yinka Ogunleye, Adesola F
AU - Wamboga, Joshua
AU - Miljković, Nenad
AU - Mwita, Julius C
AU - Rwegerera, Godfrey Mutashambara
AU - Massele, Amos
AU - Okwen, Patrick
AU - Niba, Loveline Lum
AU - Nsaikila, Melaine
AU - Rashed, Wafaa M
AU - Hussein, Mohamed Ali
AU - Hegazy, Rehab
AU - Amu, Adefolarin A
AU - Boahen-Boaten, Baffour Boaten
AU - Matsebula, Zinhle
AU - Gwebu, Prudence
AU - Chirigo, Bongani
AU - Mkhabela, Nongabisa
AU - Dlamini, Tenelisiwe
AU - Sithole, Siphiwe
AU - Malaza, Sandile
AU - Dlamini, Sikhumbuzo
AU - Afriyie, Daniel
AU - Asare, George Awuku
AU - Amponsah, Seth Kwabena
AU - Sefah, Israel
AU - Oluka, Margaret
AU - Guantai, Anastasia N
AU - Opanga, Sylvia A
AU - Sarele, Tebello Violet
AU - Mafisa, Refeletse Keabetsoe
AU - Chikowe, Ibrahim
AU - Khuluza, Felix
AU - Kibuule, Dan
AU - Kalemeera, Francis
AU - Mubita, Mwangana
AU - Fadare, Joseph
AU - Sibomana, Laurien
AU - Ramokgopa, Gwendoline Malegwale
AU - Whyte, Carmen
AU - Maimela, Tshegofatso
AU - Hugo, Johannes
AU - Meyer, Johanna C.
AU - Schellack, Natalie
AU - Rampamba, Enos M
AU - Visser, Adel
AU - Alfadl, Abubakr
AU - Malik, Elfatih M
AU - Malande, Oliver Ombeva
AU - Kalungia, Aubrey C
AU - Mwila, Chiluba
AU - Zaranyika, Trust
AU - Chaibva, Blessmore Vimbai
AU - Olaru, Ioana D.
AU - Masuka, Nyasha
AU - Wale, Janney
AU - Hwenda, Lenias
AU - Kamoga, Regina
AU - Hill, Ruaraidh
AU - Barbui, Corrado
AU - Bochenek, Tomasz
AU - Kurdi, Amanj
AU - Campbell, Stephen
AU - Martin, Antony P
AU - Phuong, Thuy Nguyen Thi
AU - Thanh Binh, Nguyen
AU - Godman, Brian
PY - 2020
DA - 2020/09/11
PB - Frontiers Media S.A.
VL - 11
PMID - 33071775
SN - 1663-9812
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Ogunleye,
author = {Olayinka O Ogunleye and Debashis Basu and Debjani Mueller and Jacqueline Sneddon and R. Andrew Seaton and Adesola F Yinka Ogunleye and Joshua Wamboga and Nenad Miljković and Julius C Mwita and Godfrey Mutashambara Rwegerera and Amos Massele and Patrick Okwen and Loveline Lum Niba and Melaine Nsaikila and Wafaa M Rashed and Mohamed Ali Hussein and Rehab Hegazy and Adefolarin A Amu and Baffour Boaten Boahen-Boaten and Zinhle Matsebula and Prudence Gwebu and Bongani Chirigo and Nongabisa Mkhabela and Tenelisiwe Dlamini and Siphiwe Sithole and Sandile Malaza and Sikhumbuzo Dlamini and Daniel Afriyie and George Awuku Asare and Seth Kwabena Amponsah and Israel Sefah and Margaret Oluka and Anastasia N Guantai and Sylvia A Opanga and Tebello Violet Sarele and Refeletse Keabetsoe Mafisa and Ibrahim Chikowe and Felix Khuluza and Dan Kibuule and Francis Kalemeera and Mwangana Mubita and Joseph Fadare and Laurien Sibomana and Gwendoline Malegwale Ramokgopa and Carmen Whyte and Tshegofatso Maimela and Johannes Hugo and Johanna C. Meyer and Natalie Schellack and Enos M Rampamba and others},
title = {Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future},
journal = {Frontiers in Pharmacology},
year = {2020},
volume = {11},
publisher = {Frontiers Media S.A.},
month = {sep},
url = {https://doi.org/10.3389/fphar.2020.01205},
doi = {10.3389/fphar.2020.01205}
}